T cell receptor repertoire as a prognosis marker for heat shock protein peptide complex-96 vaccine...
来源：康尔诺生物技术文献2020-04-12
Zhang Y, Mudgal P, Wang L, Wu H, Huang N, Alexander PB, Gao Z, Ji N, Li QJ. T cell receptor repertoire as a prognosis marker for heat shock protein peptide complex-96 vaccine trial against newly diagnosed glioblastoma. Oncoimmunology. 2020 Apr 12;9(1):1749476. doi: 10.1080/2162402X.2020.1749476.
相关资讯
Low MxA Expression Predicts Better Immunotherapeutic Outcomes in Glioblastoma Patients ...
2025-12-08
Chinese consensus on the diagnosis and treatment of gastric cancer with liver metastases
2025-12-08
Resection of Noncontrast-Enhancing Regions Deteriorated the Immunotherapeutic Efficacy of ...
2022-05-18
胃癌肝转移诊断与综合治疗中国专家共识（2019版）
2019-05-01
Heat shock protein peptide complex-96 vaccination for newly diagnosed glioblastoma: a phase I, single-arm trial
2018-05-17